Mednax Net Income Per Share from 2010 to 2026

MD Stock  USD 21.00  0.33  1.60%   
Mednax's Net Loss is decreasing over the years with slightly volatile fluctuation. Overall, Net Loss is projected to go to -1.3 this year. During the period from 2010 to 2026 Mednax Net Loss annual values regression line had geometric mean of  2.05 and mean square error of  29.19. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(1.37)
Current Value
(1.30)
Quarterly Volatility
5.50571011
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.8 M, Interest Expense of 25.2 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 1.56. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
Build AI portfolio with Mednax Stock
Check out the analysis of Mednax Correlation against competitors.
Analyzing Mednax's Net Income Per Share over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Per Share has evolved provides context for assessing Mednax's current valuation and future prospects.

Latest Mednax's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Mednax Inc over the last few years. It is Mednax's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

Mednax Net Income Per Share Regression Statistics

Arithmetic Mean(0.29)
Geometric Mean2.05
Coefficient Of Variation(1,875)
Mean Deviation3.52
Median1.52
Standard Deviation5.51
Sample Variance30.31
Range21.3651
R-Value(0.31)
Mean Square Error29.19
R-Squared0.1
Significance0.22
Slope(0.34)
Total Sum of Squares485.01

Mednax Net Income Per Share History

2026 -1.3
2025 -1.37
2024 -1.19
2023 -0.72
2022 0.8
2021 1.52
2020 -9.31

About Mednax Financial Statements

Mednax stakeholders use historical fundamental indicators, such as Mednax's Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss(1.37)(1.30)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Mednax Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
2.652
Earnings Share
1.91
Revenue Per Share
22.778
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0686
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value—what Mednax's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.